Hart Daniel R's Form 4 filing
Avid Bioservices, Inc. (CDMO) · filed Jul 12, 2022
- Accession no.
- 0001683168-22-004919
- Filed
- Jul 12, 2022
- Trade date
- Jul 9-11, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 5 derivative transactions. Open-market sales total $76.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hart Daniel RCIK 0001346342 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2022 | Common Stock, $0.001 par value | MOption exerciseAcquired | +1,520 | –F1 | – | 38,263 | Direct | |
| Jul 10, 2022 | Common Stock, $0.001 par value | MOption exerciseAcquired | +5,866 | –F1 | – | 44,129 | Direct | |
| Jul 10, 2022 | Common Stock, $0.001 par value | MOption exerciseAcquired | +4,856 | –F1 | – | 48,985 | Direct | |
| Jul 11, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −4,324 | $17.75F3 | −$76,751 | 44,661 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2022 | Common Stock | AGrant or awardAcquired | +67,247 | $0.00 | $0 | 99,675 | Direct | |
| Jul 9, 2022 | Common Stock | AGrant or awardAcquired | +33,623 | $0.00 | $0 | 79,685 | Direct | |
| Jul 9, 2022 | Common Stock | MOption exerciseDisposed | −1,520 | $0.00 | $0 | 78,165 | Direct | |
| Jul 10, 2022 | Common Stock | MOption exerciseDisposed | −5,866 | $0.00 | $0 | 72,299 | Direct | |
| Jul 10, 2022 | Common Stock | MOption exerciseDisposed | −4,856 | $0.00 | $0 | 67,443 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Referenced by the price of 3 transactions in Table I.
- F3
Represents a weighted average sales price per share. These shares were sold at prices ranging from $17.75 to $18.06. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.